首页 > 最新文献

Chemistry Central Journal最新文献

英文 中文
Synthesis and evaluation of antimicrobial, antitubercular and anticancer activities of 2-(1-benzoyl-1H-benzo[d]imidazol-2-ylthio)-N-substituted acetamides. 2-(1-苯甲酰基-1H-苯并[d]咪唑-2-硫基)-N-取代乙酰胺的合成及抗菌、抗结核和抗癌活性评价。
Q1 Chemistry Pub Date : 2018-05-26 DOI: 10.1186/s13065-018-0432-3
Snehlata Yadav, Siong Meng Lim, Kalavathy Ramasamy, Mani Vasudevan, Syed Adnan Ali Shah, Abhishek Mathur, Balasubramanian Narasimhan

Background: The study describes the synthesis, characterization, in vitro antimicrobial and anticancer evaluation of a series of 2-(1-benzoyl-1H-benzo[d]imidazol-2-ylthio)-N-substituted acetamide derivatives. The synthesized derivatives were also assessed for in vitro antitubercular activity against Mycobacterium tuberculosis H37Rv. The compounds found active in in vitro study were assessed for their in vivo antitubercular activity in mice models and for their inhibitory action on vital mycobacterial enzymes viz, isocitrate lyase, pantothenate synthetase and chorismate mutase.

Results: Compounds 8, 9 and 11 emerged out as excellent antimicrobial agents in antimicrobial assays when compared to standard antibacterial and antifungal drugs. The results of anticancer activity displayed that majority of the derivatives were less cytotoxic than standard drugs (tamoxifen and 5-fluorouracil) towards MCF7 and HCT116 cell lines. However, compound 2 (IC50 = 0.0047 µM/ml) and compound 10 (IC50 = 0.0058 µM/ml) showed highest cytotoxicity against MCF7 and HCT116 cell lines, respectively. The results of in vivo antitubercular activity revealed that a dose of 1.34 mg/kg was found to be safe for the synthesized compounds. The toxic dose of the compounds was 5.67 mg/kg while lethal dose varied from 1.81 to 3.17 mg/kg body weight of the mice. Compound 18 inhibited all the three mycobacterial enzymes to the highest level in comparison to the other synthesized derivatives but showed lesser inhibition as compared to streptomycin sulphate.

Conclusions: A further research on most active synthesized compounds as lead molecules may result in discovery of novel anticancer and antitubercular agents.

背景:本研究描述了一系列 2-(1-苯甲酰基-1H-苯并[d]咪唑-2-硫基)-N-取代乙酰胺衍生物的合成、表征、体外抗菌和抗癌评估。还评估了合成的衍生物对结核分枝杆菌 H37Rv 的体外抗结核活性。对在体外研究中发现具有活性的化合物进行了小鼠模型体内抗结核活性评估,并评估了它们对重要的分枝杆菌酶,即异柠檬酸裂解酶、泛酸合成酶和氯氨酸变异酶的抑制作用:结果:与标准抗菌药和抗真菌药相比,化合物 8、9 和 11 在抗菌试验中表现出卓越的抗菌效果。抗癌活性结果表明,大多数衍生物对 MCF7 和 HCT116 细胞系的细胞毒性低于标准药物(他莫昔芬和 5-氟尿嘧啶)。然而,化合物 2(IC50 = 0.0047 µM/ml)和化合物 10(IC50 = 0.0058 µM/ml)分别对 MCF7 和 HCT116 细胞株表现出最高的细胞毒性。体内抗结核活性结果显示,合成化合物的安全剂量为 1.34 mg/kg。化合物的毒性剂量为 5.67 毫克/千克,致死剂量为 1.81 至 3.17 毫克/千克体重。与其他合成衍生物相比,化合物 18 对三种霉菌酶的抑制作用最强,但与硫酸链霉素相比,抑制作用较弱:结论:将最活跃的合成化合物作为先导分子进行进一步研究,可能会发现新型抗癌和抗结核药物。
{"title":"Synthesis and evaluation of antimicrobial, antitubercular and anticancer activities of 2-(1-benzoyl-1H-benzo[d]imidazol-2-ylthio)-N-substituted acetamides.","authors":"Snehlata Yadav, Siong Meng Lim, Kalavathy Ramasamy, Mani Vasudevan, Syed Adnan Ali Shah, Abhishek Mathur, Balasubramanian Narasimhan","doi":"10.1186/s13065-018-0432-3","DOIUrl":"10.1186/s13065-018-0432-3","url":null,"abstract":"<p><strong>Background: </strong>The study describes the synthesis, characterization, in vitro antimicrobial and anticancer evaluation of a series of 2-(1-benzoyl-1H-benzo[d]imidazol-2-ylthio)-N-substituted acetamide derivatives. The synthesized derivatives were also assessed for in vitro antitubercular activity against Mycobacterium tuberculosis H37Rv. The compounds found active in in vitro study were assessed for their in vivo antitubercular activity in mice models and for their inhibitory action on vital mycobacterial enzymes viz, isocitrate lyase, pantothenate synthetase and chorismate mutase.</p><p><strong>Results: </strong>Compounds 8, 9 and 11 emerged out as excellent antimicrobial agents in antimicrobial assays when compared to standard antibacterial and antifungal drugs. The results of anticancer activity displayed that majority of the derivatives were less cytotoxic than standard drugs (tamoxifen and 5-fluorouracil) towards MCF7 and HCT116 cell lines. However, compound 2 (IC<sub>50</sub> = 0.0047 µM/ml) and compound 10 (IC<sub>50</sub> = 0.0058 µM/ml) showed highest cytotoxicity against MCF7 and HCT116 cell lines, respectively. The results of in vivo antitubercular activity revealed that a dose of 1.34 mg/kg was found to be safe for the synthesized compounds. The toxic dose of the compounds was 5.67 mg/kg while lethal dose varied from 1.81 to 3.17 mg/kg body weight of the mice. Compound 18 inhibited all the three mycobacterial enzymes to the highest level in comparison to the other synthesized derivatives but showed lesser inhibition as compared to streptomycin sulphate.</p><p><strong>Conclusions: </strong>A further research on most active synthesized compounds as lead molecules may result in discovery of novel anticancer and antitubercular agents.</p>","PeriodicalId":9842,"journal":{"name":"Chemistry Central Journal","volume":"12 1","pages":"66"},"PeriodicalIF":0.0,"publicationDate":"2018-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971037/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36134625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis and anticancer evaluation of some novel pyrimido[5,4-e][1,2,4]triazines and pyrazolo[3,4-d]pyrimidine using DMF-DMA as methylating and cyclizing agent. 以DMF-DMA为甲基化和环化剂的新型嘧啶[5,4-e][1,2,4]三嗪和吡唑[3,4-d]嘧啶的合成及抗癌评价。
Q1 Chemistry Pub Date : 2018-05-23 DOI: 10.1186/s13065-018-0424-3
Samar A El-Kalyoubi

Background: Described a series of main target compounds pyrimido[5,4-e][1,2,4]triazines is obtained via condensation of 6-hydrazinyluracil with different aromatic aldehydes to give the hydrazones followed by nitrosation with HNO2 then intramolecular cyclization. On the other hand, pyrazolopyrimidines can be obtained by the reaction of hydrazones with dimethylformamide-dimethylacetal (DMF-DMA), DMF-DMA in the presence of DMF or by refluxing the hydrazinyluracil with DMF-DMA in the presence of DMF directly. The newly synthesized compounds are evaluated in vitro for their anticancer activity against human lung carcinoma (A549).

Results: A newly substituted compounds of benzaldehyde-pyrimidin-4-yl)hydrazones (5a-f), pyrimido[5,4-e][1,2,4]triazines 6a-e, arylethylidenehydrazinylpyrimidine 7a,b and pyrazolopyrimidines 9,11 are screened for cytotoxic activity against human lung carcinoma (A549) cell line. They exhibited a good yield. Compound 6b shows the highest effect with IC50 value 3.6 μM, followed by compounds 9, 5a, 8, 5e, 6e, 5b, 5f, 7a, 5c, 6c, 7b, 6a, 11, 5d and 6d.

Conclusion: A simple and efficient route is used for the synthesis of pyrimido[5,4-e][1,2,4]triazines and pyrazolopyrimidines. The synthesized compounds are screened for antitumor activity.

背景:描述了一系列主要目标化合物嘧啶[5,4-e][1,2,4]三嗪通过6-肼酰尿嘧啶与不同芳香醛缩合得到腙,然后用HNO2亚硝化,然后分子内环化。另一方面,腙与二甲基甲酰胺-二甲基缩醛(DMF- dma)反应,DMF- dma在DMF存在下反应,或在DMF存在下将肼尿嘧啶与DMF- dma直接回流得到吡唑并嘧啶。体外评价了新合成的化合物对人肺癌(A549)的抗肿瘤活性。结果:筛选到新取代的苯甲醛-嘧啶-4-酰基腙(5a-f)、嘧啶[5,4-e][1,2,4]三嗪6a-e、芳基乙基肼基嘧啶7a、b和吡唑嘧啶9、11对人肺癌(A549)细胞株具有细胞毒活性。他们的产量很高。化合物6b的IC50值最高,为3.6 μM,其次为化合物9、5a、8、5e、6e、5b、5f、7a、5c、6c、7b、6a、11、5d和6d。结论:为合成嘧啶[5,4-e][1,2,4]三嗪和吡唑并嘧啶提供了一条简便、高效的途径。对合成的化合物进行抗肿瘤活性筛选。
{"title":"Synthesis and anticancer evaluation of some novel pyrimido[5,4-e][1,2,4]triazines and pyrazolo[3,4-d]pyrimidine using DMF-DMA as methylating and cyclizing agent.","authors":"Samar A El-Kalyoubi","doi":"10.1186/s13065-018-0424-3","DOIUrl":"https://doi.org/10.1186/s13065-018-0424-3","url":null,"abstract":"<p><strong>Background: </strong>Described a series of main target compounds pyrimido[5,4-e][1,2,4]triazines is obtained via condensation of 6-hydrazinyluracil with different aromatic aldehydes to give the hydrazones followed by nitrosation with HNO<sub>2</sub> then intramolecular cyclization. On the other hand, pyrazolopyrimidines can be obtained by the reaction of hydrazones with dimethylformamide-dimethylacetal (DMF-DMA), DMF-DMA in the presence of DMF or by refluxing the hydrazinyluracil with DMF-DMA in the presence of DMF directly. The newly synthesized compounds are evaluated in vitro for their anticancer activity against human lung carcinoma (A549).</p><p><strong>Results: </strong>A newly substituted compounds of benzaldehyde-pyrimidin-4-yl)hydrazones (5a-f), pyrimido[5,4-e][1,2,4]triazines 6a-e, arylethylidenehydrazinylpyrimidine 7a,b and pyrazolopyrimidines 9,11 are screened for cytotoxic activity against human lung carcinoma (A549) cell line. They exhibited a good yield. Compound 6b shows the highest effect with IC<sub>50</sub> value 3.6 μM, followed by compounds 9, 5a, 8, 5e, 6e, 5b, 5f, 7a, 5c, 6c, 7b, 6a, 11, 5d and 6d.</p><p><strong>Conclusion: </strong>A simple and efficient route is used for the synthesis of pyrimido[5,4-e][1,2,4]triazines and pyrazolopyrimidines. The synthesized compounds are screened for antitumor activity.</p>","PeriodicalId":9842,"journal":{"name":"Chemistry Central Journal","volume":"12 1","pages":"64"},"PeriodicalIF":0.0,"publicationDate":"2018-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13065-018-0424-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36127715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles. 通过表面修饰的可生物降解聚合物纳米颗粒提高阿霉素的口服生物利用度。
Q1 Chemistry Pub Date : 2018-05-23 DOI: 10.1186/s13065-018-0434-1
Niyaz Ahmad, Rizwan Ahmad, Md Aftab Alam, Farhan Jalees Ahmad

Background: Doxorubicin hydrochloride (DOX·HCl), an anthracycline glycoside antibiotic, exhibits low oral bioavailability due to active efflux from intestinal P-glycoprotein receptors. The oral administration of DOX remains a challenge hence; no oral formulation for DOX is marketed, till date.

Aim of the study: To improve the oral bioavailability of DOX through, preparation of a nanoformulation i.e. PEGylated-doxorubicin(DOX)-loaded-poly-lactic-co-glycolic acid (PLGA)-Nanoparticles (NPs) and to develop and validate an ultra-high performance liquid chromatography electrospray ionization-synapt mass spectrometric bioanalytical method (UHPLC/ESI-QTOF-MS/MS) for plasma (Wistar rats) DOX quantification.

Materials and methods: For chromatography, Waters ACQUITY UPLC™ along with a BEH C-18 column (2.1 mm × 100 mm; 1.7 μm), mobile phase conditions (acetonitrile: 0.1% formic acid::1:1 v/v) and flow rate (0.20 ml/min) was used. For analyte recovery from rat plasma, a liquid-liquid extraction method (LLE), using Acetonitrile: 5 mM ammonium acetate in a ratio of 6:4 v/v at pH 3.5, was used.

Results: Nanoformulation with a particle size (183.10 ± 7.41 nm), zeta potential (- 13.10 ± 1.04 mV), drug content (42.69 ± 1.97 µg/mg) and a spherical shape and smooth surface was developed. An elution time of 1.61 and 1.75 min along with a transition at m/z 544.42/397.27 and 528.46/321.41 were observed for DOX and internal standard (IS) Daunorubicin, respectively. In addition, a linear dynamic range with r2 ≥ 0.9985 over a concentration range of 1.00-2500.0 ng/ml was observed for different processes and parameters used in the study. Similarly a marked improvement i.e. 6.8 fold was observed, in PEGylated-DOX-PLGA-NPs as compared to DOX-S, in pharmacokinetics studies.

Conclusion: The promising approach of PEGylated-DOX-PLGA-NPs may provide an alternate to intravenous therapy for better patient care.

背景:盐酸阿霉素(DOX·HCl)是一种蒽环类糖苷类抗生素,由于肠道p糖蛋白受体的主动外排,口服生物利用度较低。因此,口服DOX仍然是一个挑战;到目前为止,还没有DOX的口服制剂上市。研究目的:通过制备聚乙二醇化阿霉素(DOX)-聚乳酸-羟基乙酸(PLGA)-纳米颗粒(NPs)纳米制剂,提高DOX的口服生物利用度,并建立并验证一种用于血浆(Wistar大鼠)DOX定量的超高效液相色谱电喷雾电离-联用质谱生物分析方法(UHPLC/ESI-QTOF-MS/MS)。材料和方法:用于色谱,Waters ACQUITY UPLC™连同BEH C-18柱(2.1 mm × 100 mm;采用流动相条件(乙腈:0.1%甲酸::1:1 v/v),流速(0.20 ml/min)。从大鼠血浆中提取分析物,采用液-液萃取法,乙腈:5 mM乙酸铵,pH为3.5,比为6:4 v/v。结果:制备出粒径为183.10±7.41 nm、zeta电位为- 13.10±1.04 mV、药物含量为42.69±1.97µg/mg、表面光滑的纳米制剂。DOX和内标(IS)柔红霉素的洗脱时间分别为1.61和1.75 min,并在m/z 544.42/397.27和528.46/321.41处发生过渡。此外,在1.00-2500.0 ng/ml浓度范围内,研究中使用的不同工艺和参数均观察到r2≥0.9985的线性动态范围。同样,在药代动力学研究中,与DOX-S相比,聚乙二醇化dox - plga - nps也有6.8倍的显著改善。结论:聚乙二醇化dox - plga - nps可能是静脉治疗的一种替代方法,可以改善患者的护理。
{"title":"Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles.","authors":"Niyaz Ahmad,&nbsp;Rizwan Ahmad,&nbsp;Md Aftab Alam,&nbsp;Farhan Jalees Ahmad","doi":"10.1186/s13065-018-0434-1","DOIUrl":"https://doi.org/10.1186/s13065-018-0434-1","url":null,"abstract":"<p><strong>Background: </strong>Doxorubicin hydrochloride (DOX·HCl), an anthracycline glycoside antibiotic, exhibits low oral bioavailability due to active efflux from intestinal P-glycoprotein receptors. The oral administration of DOX remains a challenge hence; no oral formulation for DOX is marketed, till date.</p><p><strong>Aim of the study: </strong>To improve the oral bioavailability of DOX through, preparation of a nanoformulation i.e. PEGylated-doxorubicin(DOX)-loaded-poly-lactic-co-glycolic acid (PLGA)-Nanoparticles (NPs) and to develop and validate an ultra-high performance liquid chromatography electrospray ionization-synapt mass spectrometric bioanalytical method (UHPLC/ESI-QTOF-MS/MS) for plasma (Wistar rats) DOX quantification.</p><p><strong>Materials and methods: </strong>For chromatography, Waters ACQUITY UPLC™ along with a BEH C-18 column (2.1 mm × 100 mm; 1.7 μm), mobile phase conditions (acetonitrile: 0.1% formic acid::1:1 v/v) and flow rate (0.20 ml/min) was used. For analyte recovery from rat plasma, a liquid-liquid extraction method (LLE), using Acetonitrile: 5 mM ammonium acetate in a ratio of 6:4 v/v at pH 3.5, was used.</p><p><strong>Results: </strong>Nanoformulation with a particle size (183.10 ± 7.41 nm), zeta potential (- 13.10 ± 1.04 mV), drug content (42.69 ± 1.97 µg/mg) and a spherical shape and smooth surface was developed. An elution time of 1.61 and 1.75 min along with a transition at m/z 544.42/397.27 and 528.46/321.41 were observed for DOX and internal standard (IS) Daunorubicin, respectively. In addition, a linear dynamic range with r<sup>2</sup> ≥ 0.9985 over a concentration range of 1.00-2500.0 ng/ml was observed for different processes and parameters used in the study. Similarly a marked improvement i.e. 6.8 fold was observed, in PEGylated-DOX-PLGA-NPs as compared to DOX-S, in pharmacokinetics studies.</p><p><strong>Conclusion: </strong>The promising approach of PEGylated-DOX-PLGA-NPs may provide an alternate to intravenous therapy for better patient care.</p>","PeriodicalId":9842,"journal":{"name":"Chemistry Central Journal","volume":"12 1","pages":"65"},"PeriodicalIF":0.0,"publicationDate":"2018-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13065-018-0434-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36127888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 54
Determination of antioxidant and antimicrobial activities of leaf extracts of Otostegia integrifolia. 耳槐叶提取物抗氧化和抗菌活性的测定。
Q1 Chemistry Pub Date : 2018-05-18 DOI: 10.1186/s13065-018-0433-2
Yiketel Adege Chekol, Zelalem Yibralign Desta

Background: The extracts from the leaves of Otostegia integrifolia have been reported to show phytochemical analysis, total flavonoid content, antioxidant and antibacterial activities.

Results: Our results revealed that the total flavonoid content of methanol and ethyl acetate extracts is 416.5 + 0.288 and 248.9 + 0.872 mgAAE/100 g respectively. The two extracts also showed good antioxidant activity as well as weak to moderate antibacterial activity against some bacteria.

Conclusions: The leaf extracts from O. integrifolia showed good total flavonoid content, DPPH radical scavenging activity and antibacterial activity. In addition to this, the extracts also showed the presence of some important compounds by phytochemical analysis.

背景:近年来已有文献报道了从整合耳术叶中提取的植物化学分析、总黄酮含量、抗氧化和抗菌活性。结果:甲醇和乙酸乙酯提取物的总黄酮含量分别为416.5 + 0.288和248.9 + 0.872 mgAAE/100 g。两种提取物均表现出良好的抗氧化活性,对某些细菌的抑菌活性较弱至中等。结论:合集叶提取物具有较好的总黄酮含量、DPPH自由基清除活性和抗菌活性。此外,通过植物化学分析还发现了一些重要的化合物。
{"title":"Determination of antioxidant and antimicrobial activities of leaf extracts of Otostegia integrifolia.","authors":"Yiketel Adege Chekol,&nbsp;Zelalem Yibralign Desta","doi":"10.1186/s13065-018-0433-2","DOIUrl":"https://doi.org/10.1186/s13065-018-0433-2","url":null,"abstract":"<p><strong>Background: </strong>The extracts from the leaves of Otostegia integrifolia have been reported to show phytochemical analysis, total flavonoid content, antioxidant and antibacterial activities.</p><p><strong>Results: </strong>Our results revealed that the total flavonoid content of methanol and ethyl acetate extracts is 416.5 + 0.288 and 248.9 + 0.872 mgAAE/100 g respectively. The two extracts also showed good antioxidant activity as well as weak to moderate antibacterial activity against some bacteria.</p><p><strong>Conclusions: </strong>The leaf extracts from O. integrifolia showed good total flavonoid content, DPPH radical scavenging activity and antibacterial activity. In addition to this, the extracts also showed the presence of some important compounds by phytochemical analysis.</p>","PeriodicalId":9842,"journal":{"name":"Chemistry Central Journal","volume":"12 1","pages":"63"},"PeriodicalIF":0.0,"publicationDate":"2018-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13065-018-0433-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36112333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Facile synthesis of α-alkoxymethyltriphenylphosphonium iodides: new application of PPh3/I2. α-烷氧基甲基三苯基碘化磷的简易合成:PPh3/I2的新应用。
Q1 Chemistry Pub Date : 2018-05-17 DOI: 10.1186/s13065-018-0421-6
Humaira Yasmeen Gondal, Zain Maqsood Cheema, Javid Hussain Zaidi, Sammer Yousuf, M Iqbal Choudhary

An efficient one pot method for the synthesis of α-alkoxymethylphosphonium iodides is developed by using PPh3/I2 combination at room temperature. Reaction conditions are found general to synthesize wide range of structurally variant alkoxymethylphosphonium iodides in high yield (70-91%). These new functionalized phosphonium salts are further used in stereoselective synthesis of vinyl ethers as well as in carbon homologation of aldehydes.

采用PPh3/I2在室温下一锅法合成了α-烷氧甲基碘化磷。发现反应条件一般,可合成多种结构变异的烷氧甲基碘化磷,收率高(70-91%)。这些新的功能化磷盐进一步用于乙烯醚的立体选择性合成以及醛的碳同源化。
{"title":"Facile synthesis of α-alkoxymethyltriphenylphosphonium iodides: new application of PPh<sub>3</sub>/I<sub>2</sub>.","authors":"Humaira Yasmeen Gondal, Zain Maqsood Cheema, Javid Hussain Zaidi, Sammer Yousuf, M Iqbal Choudhary","doi":"10.1186/s13065-018-0421-6","DOIUrl":"10.1186/s13065-018-0421-6","url":null,"abstract":"<p><p>An efficient one pot method for the synthesis of α-alkoxymethylphosphonium iodides is developed by using PPh<sub>3</sub>/I<sub>2</sub> combination at room temperature. Reaction conditions are found general to synthesize wide range of structurally variant alkoxymethylphosphonium iodides in high yield (70-91%). These new functionalized phosphonium salts are further used in stereoselective synthesis of vinyl ethers as well as in carbon homologation of aldehydes.</p>","PeriodicalId":9842,"journal":{"name":"Chemistry Central Journal","volume":"12 1","pages":"62"},"PeriodicalIF":0.0,"publicationDate":"2018-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13065-018-0421-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36110401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Characterization of in vivo metabolites in rat urine following an oral dose of masitinib by liquid chromatography tandem mass spectrometry. 利用液相色谱串联质谱法确定大鼠口服马西替尼后尿液中体内代谢物的特征。
Q1 Chemistry Pub Date : 2018-05-15 DOI: 10.1186/s13065-018-0429-y
Adnan A Kadi, Sawsan M Amer, Hany W Darwish, Mohamed W Attwa

Masitinib (MST) is an orally administered drug that targets mast cells and macrophages, important cells for immunity, by inhibiting a limited number of tyrosine kinases. It is currently registered in Europe and USA for the treatment of mast cell tumors in dogs. AB Science announced that the European Medicines Agency has accepted a conditional marketing authorization application for MST to treat amyotrophic lateral sclerosis. In our work, we focused on studying in vivo metabolism of MST in Sprague-Dawley rats. Single oral dose of MST (33 mg kg-1) was given to Sprague-Dawley rats (kept in metabolic cages) using oral gavage. Urine was collected and filtered at 0, 6, 12, 18, 24, 48, 72 and 96 h from MST dosing. An equal amount of ACN was added to urine samples. Both organic and aqueous layers were injected into liquid chromatography-tandem mass spectrometry (LC-MS/MS) to detect in vivo phase I and phase II MST metabolites. The current work reports the identification and characterization of twenty in vivo phase I and four in vivo phase II metabolites of MST by LC-MS/MS. Phase I metabolic pathways were reduction, demethylation, hydroxylation, oxidative deamination, oxidation and N-oxide formation. Phase II metabolic pathways were the direct conjugation of MST, N-demethyl metabolites and oxidative metabolites with glucuronic acid. Part of MST dose was excreted unchanged in urine. The literature review showed no previous articles have been made on in vivo metabolism of MST or detailed structural identification of the formed in vivo phase I and phase II metabolites.

马西替尼(Mastitinib,MST)是一种口服药物,通过抑制有限的几种酪氨酸激酶来靶向肥大细胞和巨噬细胞(免疫的重要细胞)。该药目前已在欧洲和美国注册,用于治疗犬肥大细胞瘤。AB Science 公司宣布,欧洲药品管理局已接受 MST 用于治疗肌萎缩性脊髓侧索硬化症的有条件上市许可申请。我们的工作重点是研究 MST 在 Sprague-Dawley 大鼠体内的代谢。采用口服灌胃法给 Sprague-Dawley 大鼠(饲养在代谢笼中)注射单剂量 MST(33 毫克/千克-1)。在服用 MST 后的 0、6、12、18、24、48、72 和 96 小时收集并过滤尿液。尿液样本中加入等量的乙腈。将有机层和水层注入液相色谱-串联质谱法(LC-MS/MS),以检测体内第一阶段和第二阶段的 MST 代谢物。目前的工作报告了通过 LC-MS/MS 对 MST 的 20 种体内 I 期代谢物和 4 种体内 II 期代谢物的鉴定和特征描述。I 期代谢途径包括还原、去甲基化、羟基化、氧化脱氨、氧化和 N-氧化物形成。第二阶段代谢途径是 MST、N-去甲基代谢物和氧化代谢物与葡萄糖醛酸直接结合。部分剂量的 MST 会以未改变的形式从尿液中排出。文献综述显示,以前没有关于 MST 体内代谢的文章,也没有关于在体内形成的 I 期和 II 期代谢物的详细结构鉴定的文章。
{"title":"Characterization of in vivo metabolites in rat urine following an oral dose of masitinib by liquid chromatography tandem mass spectrometry.","authors":"Adnan A Kadi, Sawsan M Amer, Hany W Darwish, Mohamed W Attwa","doi":"10.1186/s13065-018-0429-y","DOIUrl":"10.1186/s13065-018-0429-y","url":null,"abstract":"<p><p>Masitinib (MST) is an orally administered drug that targets mast cells and macrophages, important cells for immunity, by inhibiting a limited number of tyrosine kinases. It is currently registered in Europe and USA for the treatment of mast cell tumors in dogs. AB Science announced that the European Medicines Agency has accepted a conditional marketing authorization application for MST to treat amyotrophic lateral sclerosis. In our work, we focused on studying in vivo metabolism of MST in Sprague-Dawley rats. Single oral dose of MST (33 mg kg<sup>-1</sup>) was given to Sprague-Dawley rats (kept in metabolic cages) using oral gavage. Urine was collected and filtered at 0, 6, 12, 18, 24, 48, 72 and 96 h from MST dosing. An equal amount of ACN was added to urine samples. Both organic and aqueous layers were injected into liquid chromatography-tandem mass spectrometry (LC-MS/MS) to detect in vivo phase I and phase II MST metabolites. The current work reports the identification and characterization of twenty in vivo phase I and four in vivo phase II metabolites of MST by LC-MS/MS. Phase I metabolic pathways were reduction, demethylation, hydroxylation, oxidative deamination, oxidation and N-oxide formation. Phase II metabolic pathways were the direct conjugation of MST, N-demethyl metabolites and oxidative metabolites with glucuronic acid. Part of MST dose was excreted unchanged in urine. The literature review showed no previous articles have been made on in vivo metabolism of MST or detailed structural identification of the formed in vivo phase I and phase II metabolites.</p>","PeriodicalId":9842,"journal":{"name":"Chemistry Central Journal","volume":"12 1","pages":"61"},"PeriodicalIF":0.0,"publicationDate":"2018-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953916/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36103364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dioscorea nipponica Makino: a systematic review on its ethnobotany, phytochemical and pharmacological profiles. Dioscorea nipponica Makino:关于其民族植物学、植物化学和药理学特征的系统综述。
Q1 Chemistry Pub Date : 2018-05-11 DOI: 10.1186/s13065-018-0423-4
Si-Hong Ou-Yang, Tao Jiang, Lin Zhu, Tao Yi

Dioscorea nipponica Makino is a perennial twining herbs belonging to the family Dioscoreaceae, which is mainly distributed in the northeastern, northern, eastern and central regions of China. Traditionally, the rhizome of this herb has been commonly used by Miao and Meng ethnic groups of China to treat rheumatoid arthritis, pain in the legs and lumbar area, Kashin Beck disease, bruises, sprains, chronic bronchitis, cough and asthma. Modern pharmacological studies have discovered that this herb possesses anti-tumor, anti-inflammatory, anti-diuretic, analgesic, anti-tussive, panting-calming and phlegm-dispelling activities, along with enhancing immune function and improving cardiovascular health. In recent years, both fat-soluble and water-soluble steroidal saponins were isolated from the rhizomes of D. nipponica using silica gel column chromatography, thin layer chromatography and high performance liquid chromatography methods. Saponin and sapogenins are mainly responsible for most of the pharmacological effects of this plant. Further, the chemical components of the aboveground parts contain more than 10 kinds of phenanthrene derivatives. The present review summarizes the knowledge concerning the geographical distribution, chemical composition, pharmacological effects, toxicology studies and clinical applications of D. nipponica.

牧野薯蓣是薯蓣科薯蓣属多年生缠绕草本植物,主要分布在中国东北、华北、华东和华中地区。传统上,中国苗族和蒙族常用这种草药的根茎治疗风湿性关节炎、腰腿疼痛、卡辛贝克病、跌打损伤、扭伤、慢性支气管炎、咳嗽和哮喘。现代药理研究发现,这种草药具有抗肿瘤、消炎、利尿、镇痛、止咳、平喘、祛痰等作用,还能增强免疫功能,改善心血管健康。近年来,利用硅胶柱色谱法、薄层色谱法和高效液相色谱法,从乳头草根中分离出脂溶性和水溶性甾体皂苷。皂苷和苷元是这种植物大部分药理作用的主要成分。此外,地上部分的化学成分中含有 10 多种菲衍生物。本综述总结了 D. nipponica 的地理分布、化学成分、药理作用、毒理学研究和临床应用等方面的知识。
{"title":"Dioscorea nipponica Makino: a systematic review on its ethnobotany, phytochemical and pharmacological profiles.","authors":"Si-Hong Ou-Yang, Tao Jiang, Lin Zhu, Tao Yi","doi":"10.1186/s13065-018-0423-4","DOIUrl":"10.1186/s13065-018-0423-4","url":null,"abstract":"<p><p>Dioscorea nipponica Makino is a perennial twining herbs belonging to the family Dioscoreaceae, which is mainly distributed in the northeastern, northern, eastern and central regions of China. Traditionally, the rhizome of this herb has been commonly used by Miao and Meng ethnic groups of China to treat rheumatoid arthritis, pain in the legs and lumbar area, Kashin Beck disease, bruises, sprains, chronic bronchitis, cough and asthma. Modern pharmacological studies have discovered that this herb possesses anti-tumor, anti-inflammatory, anti-diuretic, analgesic, anti-tussive, panting-calming and phlegm-dispelling activities, along with enhancing immune function and improving cardiovascular health. In recent years, both fat-soluble and water-soluble steroidal saponins were isolated from the rhizomes of D. nipponica using silica gel column chromatography, thin layer chromatography and high performance liquid chromatography methods. Saponin and sapogenins are mainly responsible for most of the pharmacological effects of this plant. Further, the chemical components of the aboveground parts contain more than 10 kinds of phenanthrene derivatives. The present review summarizes the knowledge concerning the geographical distribution, chemical composition, pharmacological effects, toxicology studies and clinical applications of D. nipponica.</p>","PeriodicalId":9842,"journal":{"name":"Chemistry Central Journal","volume":"12 1","pages":"57"},"PeriodicalIF":0.0,"publicationDate":"2018-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945570/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36087555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BODIPY dyads and triads: synthesis, optical, electrochemical and transistor properties. BODIPY二极体和三极体:合成、光学、电化学和晶体管性能。
Q1 Chemistry Pub Date : 2018-05-11 DOI: 10.1186/s13065-018-0430-5
Sompit Wanwong, Piyachai Khomein, S Thayumanavan

A series of D-A dyads and D-A-D triads molecular systems based on triphenylamine and 9-ethyl-carbarzole as donor (D) and BODIPY as acceptor (A) has been designed and synthesized. The optoelectronic properties including optical, electrochemical, and charge carrier mobility of these molecules have been investigated. We found that the D-A-D triads exhibited broader absorption, raising the HOMO energy levels and increase hole carrier mobilities. Analysis surface morphology revealed that BODIPY containing carbazole demonstrated smooth film and no macro phase aggregation was observed upon thermal annealing.

设计合成了以三苯胺和9-乙基卡巴唑为供体(D), BODIPY为受体(A)的一系列D-A二联体和D-A-D三联体分子体系。研究了这些分子的光电性质,包括光学、电化学和载流子迁移率。我们发现,D-A-D三元组表现出更广泛的吸收,提高了HOMO能级,增加了空穴载流子迁移率。表面形貌分析表明,含咔唑的BODIPY薄膜光滑,热处理后无宏观相聚集现象。
{"title":"BODIPY dyads and triads: synthesis, optical, electrochemical and transistor properties.","authors":"Sompit Wanwong,&nbsp;Piyachai Khomein,&nbsp;S Thayumanavan","doi":"10.1186/s13065-018-0430-5","DOIUrl":"https://doi.org/10.1186/s13065-018-0430-5","url":null,"abstract":"<p><p>A series of D-A dyads and D-A-D triads molecular systems based on triphenylamine and 9-ethyl-carbarzole as donor (D) and BODIPY as acceptor (A) has been designed and synthesized. The optoelectronic properties including optical, electrochemical, and charge carrier mobility of these molecules have been investigated. We found that the D-A-D triads exhibited broader absorption, raising the HOMO energy levels and increase hole carrier mobilities. Analysis surface morphology revealed that BODIPY containing carbazole demonstrated smooth film and no macro phase aggregation was observed upon thermal annealing.</p>","PeriodicalId":9842,"journal":{"name":"Chemistry Central Journal","volume":"12 1","pages":"60"},"PeriodicalIF":0.0,"publicationDate":"2018-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13065-018-0430-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36088107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Structural determinants influencing halogen bonding: a case study on azinesulfonamide analogs of aripiprazole as 5-HT1A, 5-HT7, and D2 receptor ligands. 影响卤素键的结构决定因素:阿立哌唑azinesulfonamide类似物作为5-HT1A、5-HT7和D2受体配体的案例研究
Q1 Chemistry Pub Date : 2018-05-11 DOI: 10.1186/s13065-018-0422-5
Krzysztof Marciniec, Rafał Kurczab, Maria Książek, Ewa Bębenek, Elwira Chrobak, Grzegorz Satała, Andrzej J Bojarski, Joachim Kusz, Paweł Zajdel

A series of azinesulfonamide derivatives of long-chain arylpiperazines with variable-length alkylene spacers between sulfonamide and 4-arylpiperazine moiety is designed, synthesized, and biologically evaluated. In vitro methods are used to determine their affinity for serotonin 5-HT1A, 5-HT6, 5-HT7, and dopamine D2 receptors. X-ray analysis, two-dimensional NMR conformational studies, and docking into the 5-HT1A and 5-HT7 receptor models are then conducted to investigate the conformational preferences of selected serotonin receptor ligands in different environments. The bent conformation of tetramethylene derivatives is found in a solid state, in dimethyl sulfoxide, and as a global energy minimum during conformational analysis in a simulated water environment. Furthermore, ligand geometry in top-scored complexes is also bent, with one torsion angle in the spacer (τ2) in synclinal conformation. Molecular docking studies indicate the role of halogen bonding in complexes of the most potent ligands and target receptors.

设计、合成了一系列在长链芳基哌嗪和4-芳基哌嗪之间有变长亚烯间隔的磺胺磺酰胺衍生物,并进行了生物学评价。采用体外方法测定其对血清素5-HT1A、5-HT6、5-HT7和多巴胺D2受体的亲和力。然后进行x射线分析、二维NMR构象研究,并对接5-HT1A和5-HT7受体模型,研究所选5-羟色胺受体配体在不同环境下的构象偏好。四亚甲基衍生物的弯曲构象在固体状态下被发现,在二甲亚砜中,并在模拟水环境的构象分析中作为全球能量最小值。此外,配体几何结构在得分最高的配合物中也是弯曲的,在向斜构象中间隔段(τ2)有一个扭转角。分子对接研究表明卤素键在最有效的配体和靶受体的配合物中的作用。
{"title":"Structural determinants influencing halogen bonding: a case study on azinesulfonamide analogs of aripiprazole as 5-HT<sub>1A</sub>, 5-HT<sub>7</sub>, and D<sub>2</sub> receptor ligands.","authors":"Krzysztof Marciniec,&nbsp;Rafał Kurczab,&nbsp;Maria Książek,&nbsp;Ewa Bębenek,&nbsp;Elwira Chrobak,&nbsp;Grzegorz Satała,&nbsp;Andrzej J Bojarski,&nbsp;Joachim Kusz,&nbsp;Paweł Zajdel","doi":"10.1186/s13065-018-0422-5","DOIUrl":"https://doi.org/10.1186/s13065-018-0422-5","url":null,"abstract":"<p><p>A series of azinesulfonamide derivatives of long-chain arylpiperazines with variable-length alkylene spacers between sulfonamide and 4-arylpiperazine moiety is designed, synthesized, and biologically evaluated. In vitro methods are used to determine their affinity for serotonin 5-HT<sub>1A</sub>, 5-HT<sub>6</sub>, 5-HT<sub>7</sub>, and dopamine D<sub>2</sub> receptors. X-ray analysis, two-dimensional NMR conformational studies, and docking into the 5-HT<sub>1A</sub> and 5-HT<sub>7</sub> receptor models are then conducted to investigate the conformational preferences of selected serotonin receptor ligands in different environments. The bent conformation of tetramethylene derivatives is found in a solid state, in dimethyl sulfoxide, and as a global energy minimum during conformational analysis in a simulated water environment. Furthermore, ligand geometry in top-scored complexes is also bent, with one torsion angle in the spacer (τ<sub>2</sub>) in synclinal conformation. Molecular docking studies indicate the role of halogen bonding in complexes of the most potent ligands and target receptors.</p>","PeriodicalId":9842,"journal":{"name":"Chemistry Central Journal","volume":"12 1","pages":"55"},"PeriodicalIF":0.0,"publicationDate":"2018-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13065-018-0422-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36090752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Dihydroisocoumarins from Radix Glycyrrhizae. 甘草酸中的二氢异香豆素。
Q1 Chemistry Pub Date : 2018-05-11 DOI: 10.1186/s13065-018-0427-0
Songsong Zhao, Xinjia Yan, Ying Zhao, Jing Wen, Zhenzhen Zhao, Hongwei Liu

Background: Radix Glycyrrhizae is the rhizome of Glycyrrhiza inflata Bat., Glycyrrhiza uralensis Fisch. or Glycyrrhiza glabra L. The present paper describes the isolation and the structural elucidation of three new dihydroisocoumarins obtained from the 70% EtOH extract of Radix Glycyrrhizae. And the cytotoxic activities of these new compounds were also evaluated using four cell lines, subsequently.

Results: A pair of new dihydroisocoumarin epimers ((3R,4S)-4,8-dihydroxy-3-methyl-1-oxoisochroman-5-yl)methyl acetate (1) and ((3R,4R)-4,8-dihydroxy-3-methyl-1-oxoisochroman-5-yl)methyl acetate (2) along with a new dihydroisocoumarin (3R,4R)-4,8-dihydroxy-3,5-dimethylisochroman-1-one (3) were isolated from Radix Glycyrrhizae. Their structures were elucidated on the basis of chemical and spectral analysis, including 1D, 2D NMR analyses, HR-ESI-MSand ECD calculation comparing with those of experimental CD spectra. Cytotoxic activities of the three compounds were evaluated using the HepG2, A549, LoVo and Hela cell lines, respectively. IC50 values indicated compounds 1-3 exhibited moderate or less cytotoxic activity in vitro.

Conclusions: Dihydroisocoumarin is not the common components in Radix Glycyrrhizae, a series of dihydroisocoumarin were obtained in this plant could be a supplement to the chemical study of this plant.

背景:甘草是一种名为Glycyrrhiza inflata Bat的植物。甘草(glycyrhiza uralensis)本文报道了从甘草70%乙醇提取物中分离得到的三种新的二氢异香豆素的分离和结构解析。并利用四种细胞系对新化合物的细胞毒活性进行了评价。结果:从甘草中分离到一对新的二氢异香豆素外映体((3R,4S)-4,8-二羟基-3-甲基-1-氧异色罗马-5-基)乙酸甲酯(1)和(3R,4R)-4,8-二羟基-3-甲基-1-氧异色罗马-5-基)乙酸甲酯(2)和一个新的二氢异香豆素(3R,4R)-4,8-二羟基-3,5-二甲基异色罗马-1-one(3)。通过化学和光谱分析,包括1D、2D NMR分析、hr - esi - mms和ECD计算,并与实验CD谱进行比较,对它们的结构进行了鉴定。分别用HepG2、A549、LoVo和Hela细胞株对三种化合物的细胞毒活性进行了评价。IC50值表明化合物1 ~ 3具有中等或较低的体外细胞毒活性。结论:双氢异香豆素不是甘草酸中常见的成分,从甘草酸中分离得到的一系列双氢异香豆素可作为对甘草酸化学研究的补充。
{"title":"Dihydroisocoumarins from Radix Glycyrrhizae.","authors":"Songsong Zhao,&nbsp;Xinjia Yan,&nbsp;Ying Zhao,&nbsp;Jing Wen,&nbsp;Zhenzhen Zhao,&nbsp;Hongwei Liu","doi":"10.1186/s13065-018-0427-0","DOIUrl":"https://doi.org/10.1186/s13065-018-0427-0","url":null,"abstract":"<p><strong>Background: </strong>Radix Glycyrrhizae is the rhizome of Glycyrrhiza inflata Bat., Glycyrrhiza uralensis Fisch. or Glycyrrhiza glabra L. The present paper describes the isolation and the structural elucidation of three new dihydroisocoumarins obtained from the 70% EtOH extract of Radix Glycyrrhizae. And the cytotoxic activities of these new compounds were also evaluated using four cell lines, subsequently.</p><p><strong>Results: </strong>A pair of new dihydroisocoumarin epimers ((3R,4S)-4,8-dihydroxy-3-methyl-1-oxoisochroman-5-yl)methyl acetate (1) and ((3R,4R)-4,8-dihydroxy-3-methyl-1-oxoisochroman-5-yl)methyl acetate (2) along with a new dihydroisocoumarin (3R,4R)-4,8-dihydroxy-3,5-dimethylisochroman-1-one (3) were isolated from Radix Glycyrrhizae. Their structures were elucidated on the basis of chemical and spectral analysis, including 1D, 2D NMR analyses, HR-ESI-MSand ECD calculation comparing with those of experimental CD spectra. Cytotoxic activities of the three compounds were evaluated using the HepG2, A549, LoVo and Hela cell lines, respectively. IC<sub>50</sub> values indicated compounds 1-3 exhibited moderate or less cytotoxic activity in vitro.</p><p><strong>Conclusions: </strong>Dihydroisocoumarin is not the common components in Radix Glycyrrhizae, a series of dihydroisocoumarin were obtained in this plant could be a supplement to the chemical study of this plant.</p>","PeriodicalId":9842,"journal":{"name":"Chemistry Central Journal","volume":"12 1","pages":"58"},"PeriodicalIF":0.0,"publicationDate":"2018-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s13065-018-0427-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36087861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Chemistry Central Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1